# An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis

> **NCT05616871** · — · ACTIVE_NOT_RECRUITING · sponsor: **AbbVie** · enrollment: 450 (estimated)

## Conditions studied

- Psoriatic Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05616871
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-12-15
- **Primary completion:** 2027-07
- **Final completion:** 2027-07
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2025-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05616871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05616871, "An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05616871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*